Your browser is not up to date and is not able to run this publication.

29TRAUMEEL® STUDIES INDICATIONS

INDICATION THERAPIES STUDY

Pediatric study

Acute musculoskeletal injury (observational study)

Traumeel® ointment Ludwig 2001

Surveillance studies

Variety of injuries (e.g. sprains, posttraumatic edema), and degenerative and inflammatory conditions (arthrosis and epicondylitis)

Traumeel® tablet or drop forms (69% tablets, 29% drops, 2% both). One-third of patients were treated without other therapies (drug and non-drug)

Zenner 1997

Variety of injuries, and degenerative and inflammatory conditions

Traumeel® ointment. Used exclusively by 38% of patients; adjuvant medications taken by 30% of patients; 52% received nonmedication therapies

Zenner 1994

Variety of injuries, and degenerative and inflammatory conditions

Traumeel® injection. Used exclusively by 17% of patients; adjuvant medications taken by 47% of patients; 65% received nonmedication therapies

Zenner 1992

Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2
Powered by Fluidbook